Skip to main content
. 2016 Feb 17;6:21608. doi: 10.1038/srep21608

Figure 4.

Figure 4

QCM-D profile of antibody conjugated LYVE-1 interaction with the 33% (a) side-alkylated and (b) end-alkylated sHA surface. For easier comparison, all values were set to zero after functionalization with OEG/sHA.